Event
Reducing Diagnostic Complexity with New Biomarkers
United States / Face-to-Face
New markers hold great potential to improve care of Autoimmune diseases. We will:
- Introduce a novel particle-based multi-analyte technology (PMAT)
- Identify the contribution of novel biomarkers in the differential diagnostics of autoimmune diseases
- Hear from a clinical perspective how multi-analyte detection of autoantibodies can help close the seronegative gap and improve clinical assessment
TO REGISTER:
Contact Maggie Fogle at AMLI: maggie@maggiefogle.com
Please contact your Inova Diagnostics sales representative or visit www.amli.org and www.inovadx.com for more information.